Canadian General Medical Center Complex Company
TADAWUL:9518.SR
5.68 (SAR) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SAR.
| 2024 Q2 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 51.224 | 55.125 | 27.562 | 45.217 | 22.609 | 42.313 | 21.156 | 38.917 | 19.458 | 40.459 | 20.23 | 30.183 | 15.092 | 34.384 | 17.192 | 29.832 | 14.916 |
| Cost of Revenue
| 39.714 | 37.796 | 18.898 | 31.005 | 15.503 | 29.969 | 14.985 | 26.288 | 13.144 | 27.659 | 13.86 | 17.791 | 8.895 | 21.408 | 11.29 | 17.609 | 8.805 |
| Gross Profit
| 11.51 | 17.329 | 8.664 | 14.212 | 7.106 | 12.343 | 6.172 | 12.629 | 6.314 | 12.8 | 6.37 | 12.393 | 6.196 | 12.975 | 5.902 | 12.223 | 6.111 |
| Gross Profit Ratio
| 0.225 | 0.314 | 0.314 | 0.314 | 0.314 | 0.292 | 0.292 | 0.325 | 0.325 | 0.316 | 0.315 | 0.411 | 0.411 | 0.377 | 0.343 | 0.41 | 0.41 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0.676 | 0.676 | 2.953 | 2.953 | 1.725 | 1.725 | 1.758 | 1.758 | 1.624 | 1.624 | 2.944 | 2.944 | 1.616 | 1.616 | 1.752 | 1.752 |
| Selling & Marketing Expenses
| 0 | 0.923 | 0.923 | 2.953 | 0 | 3.152 | 0.756 | 1.758 | 0 | 1.381 | -0.234 | 2.944 | 0 | 2.918 | 0.15 | 1.752 | 0 |
| SG&A
| 7.632 | 3.268 | 5.035 | 5.906 | 2.953 | 4.198 | 2.181 | 3.516 | 1.758 | 3.004 | 1.39 | 5.888 | 2.944 | 4.534 | 1.766 | 3.503 | 1.752 |
| Other Expenses
| 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 7.632 | 3.268 | 5.525 | 5.906 | 2.352 | 4.198 | 2.126 | 3.516 | 1.577 | 3.004 | 1.224 | 5.888 | 2.903 | 4.534 | 1.845 | 3.503 | 1.618 |
| Operating Income
| 3.878 | 14.06 | 3.629 | 8.306 | 4.153 | 8.145 | 3.991 | 9.112 | 4.556 | 9.796 | 4.841 | 6.505 | 3.253 | 8.442 | 4.136 | 8.72 | 4.36 |
| Operating Income Ratio
| 0.076 | 0.255 | 0.132 | 0.184 | 0.184 | 0.192 | 0.189 | 0.234 | 0.234 | 0.242 | 0.239 | 0.216 | 0.216 | 0.246 | 0.241 | 0.292 | 0.292 |
| Total Other Income Expenses Net
| 0.973 | -5.371 | 0.716 | 0.866 | 0.433 | 0.639 | 0.402 | 0.075 | 0.038 | 0.409 | 0.261 | -0.181 | -0.091 | -0.384 | -0.108 | -0.066 | -0.033 |
| Income Before Tax
| 4.851 | 8.689 | 4.345 | 9.173 | 4.586 | 8.784 | 4.392 | 9.188 | 4.594 | 10.205 | 5.102 | 6.324 | 3.162 | 8.057 | 4.029 | 8.654 | 4.327 |
| Income Before Tax Ratio
| 0.095 | 0.158 | 0.158 | 0.203 | 0.203 | 0.208 | 0.208 | 0.236 | 0.236 | 0.252 | 0.252 | 0.21 | 0.21 | 0.234 | 0.234 | 0.29 | 0.29 |
| Income Tax Expense
| 1.482 | 0.98 | 0.49 | 1.172 | 0.586 | 1.068 | 0.534 | 1.25 | 0.625 | 1.104 | 0.552 | 1.361 | 0.681 | 0.303 | 0.152 | 0.255 | 0.128 |
| Net Income
| 3.37 | 7.709 | 3.855 | 8.001 | 4.001 | 7.716 | 3.858 | 7.938 | 3.969 | 9.101 | 4.55 | 4.963 | 2.481 | 7.754 | 3.877 | 8.399 | 4.2 |
| Net Income Ratio
| 0.066 | 0.14 | 0.14 | 0.177 | 0.177 | 0.182 | 0.182 | 0.204 | 0.204 | 0.225 | 0.225 | 0.164 | 0.164 | 0.226 | 0.226 | 0.282 | 0.282 |
| EPS
| 0.044 | 0.1 | 0.05 | 0.1 | 0.052 | 0.1 | 0.05 | 0.1 | 0.052 | 0.12 | 0.059 | 0.065 | 0.032 | 0.1 | 0.51 | 83.99 | 42 |
| EPS Diluted
| 0.044 | 0.1 | 0.05 | 0.1 | 0.052 | 0.1 | 0.05 | 0.1 | 0.052 | 0.12 | 0.059 | 0.065 | 0.032 | 0.1 | 0.51 | 83.99 | 42 |
| EBITDA
| 5.64 | 14.601 | 3.676 | 9.501 | 4.564 | 10.028 | 4.495 | 10.373 | 5.012 | 11.312 | 5.423 | 7.927 | 3.787 | 10.15 | 4.814 | 9.842 | 4.745 |
| EBITDA Ratio
| 0.11 | 0.265 | 0.133 | 0.21 | 0.202 | 0.237 | 0.212 | 0.267 | 0.258 | 0.28 | 0.268 | 0.263 | 0.251 | 0.295 | 0.28 | 0.33 | 0.318 |